KAIFENG MINGREN PHARMACEUTICAL CO.,LTD.
|
It is currently the only new type of aldose reductase (AR) inhibitor. By inhibiting the formation of sorbitol, it improves the subjective symptoms (numbness, pain) and abnormal nerve functions of diabetic peripheral neuropathy, and is used as a drug for the treatment of diabetic neuropathy. |
Send Inquiry
|